(Q38456532)

English

Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial

scientific article published on February 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

peripheral artery disease

1 reference

based on heuristic

inferred from title

intermittent claudication

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Jonathan Golledge

8

object named as

Jonathan Golledge

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Anthony S Leicht

4

object named as

Anthony Leicht

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Christopher M Reid

7

object named as

Christopher M Reid

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

author name string

Anna A Ahimastos

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Philip J Walker

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Christopher Askew

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Elise Pappas

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Peter Blombery

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Bronwyn A Kingwell

9

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

0 references

publication date

1 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

The Journal of the American Medical Association

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

309

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

453-460

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

ACE-inhibition and physical function: results from the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Corridor-based functional performance measures correlate better with physical activity during daily life than treadmill measures in persons with peripheral arterial disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Exercise training improves functional status in patients with peripheral arterial disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Skeletal muscle angiotensin-converting enzyme and its relationship to blood pressure in primary hypertension and healthy elderly men

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

The effect of treatment with low dose ACE inhibitor and/or diuretic on coronary microvasculature in stroke-prone spontaneously hypertensive rats

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Reliability of treadmill testing in peripheral arterial disease: a comparison of a constant load with a graded load treadmill protocol

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Physical Training and Antiplatelet Treatment in Stage II Peripheral Arterial Occlusive Disease: Alone or Combined?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Cardiovascular protective role of a low-dose antihypertensive combination in obese Zucker rats

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Effects of policosanol and ticlopidine in patients with intermittent claudication: a double-blinded pilot comparative study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

The perindopril in elderly people with chronic heart failure (PEP-CHF) study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Double-blind comparison of captopril with nifedipine in hypertension complicated by intermittent claudication

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Angiotensin-converting enzyme inhibitor use and incident frailty in women aged 65 and older: prospective findings from the Women's Health Initiative Observational Study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Structural adaptation to ischemia in skeletal muscle: effects of blockers of the renin-angiotensin system

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Reproducibility of constant-load treadmill testing with various treadmill protocols and predictability of treadmill test results in patients with intermittent claudication

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Bradykinin enhances GLUT4 translocation through the increase of insulin receptor tyrosine kinase in primary adipocytes: evidence that bradykinin stimulates the insulin signalling pathway

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

A randomized trial of iloprost in patients with intermittent claudication

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Angiotensin-converting enzyme inhibition improves defective angiogenesis in the ischemic limb of spontaneously hypertensive rats

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Peripheral arterial Doppler ultrasonography: diagnostic criteria

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

ACE-inhibition with perindopril in essential hypertensive patients with concomitant diseases. The Perindopril Therapeutic Safety Collaborative Research Group

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Strategies for Multiple Imputation in Longitudinal Studies

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Skeletal muscle changes in patients with chronic heart failure before and after treatment with enalapril

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

A comparison of cilostazol and pentoxifylline for treating intermittent claudication

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Effect of long-term ACE inhibition on myocardial tissue in hypertensive stroke-prone rats

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Medical management of the patient with intermittent claudication

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Oral Beraprost sodium, a prostaglandin I(2) analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Do angiotensin converting enzyme inhibitors improve walking distance in patients with symptomatic lower limb arterial disease? A systematic review and meta-analysis of randomised controlled trials

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Multiple imputation: review of theory, implementation and software

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Antihypertensive medications and differences in muscle mass in older persons: the Health, Aging and Body Composition Study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1001/JAMA.2012.216237

Identifiers

10.1001/JAMA.2012.216237

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38456532&oldid=2063187126"